Top Markets
#1 MowCat MowCat +49.01%
#2 Velvet Velvet +26.59%
#3 Bermuda Shorts Bermuda Shorts +25.22%
#4 Biconomy Biconomy +21.45%
#5 Derive Derive +20.93%
#6 Audiera Audiera +19.36%
#7 Quack AI Quack AI +19.08%
#8 aPriori aPriori +18.64%
#9 Perle Perle +12.16%
#10 DODO DODO +11.93%
Coin of the day
MowCat MowCat
Innstillinger
Språk
NORSK
Valuta
USD
Tema
RLS Global AB (publ) RLS Global AB (publ)

RLS Global AB (publ)

RLS
Rangering i aksjer #35382
RLS Global AB (publ) is a Swedish medical technology firm that specializes in... RLS Global AB (publ) is a Swedish medical technology firm that specializes in developing and commercializing therapeutic products for conditions within wound and oral care. Among its key offerings are ChloraSolv, a treatment specifically designed for chronic diabetic foot and leg ulcers in diabetic patients, and CariSolv, a unique gel employed for the removal of dental caries. Established in 1996, the company maintains its headquarters in Mölndal, Sweden.
Aksjekurs
$0.04981532
Sist synkronisert: 2024-07-12
Markedsverdi
$3.99M
Endring (1 dag)
13.82%
Endring (1 år)
0.00%
Land
SE
Handel RLS Global AB (publ) (RLS)

Kategori

Healthcare
Utbytteavkastning for RLS Global AB (publ) (RLS)
RLS Global AB (publ) (aksjesymbol: RLS) sin utbytteavkastning (TTM) per 2026 er: 0
Gjennomsnittlig utbytteavkastning de siste 5 årene: 0.00%
Utbytteavkastning for RLS Global AB (publ) (RLS) fra 2026 til 2026
Utbytteavkastning ved slutten av hvert år (TTM)
År Utbytteavkastning Endre
Ikke nok data for de angitte datoene.
Utbytteavkastning (TTM) for lignende selskaper eller konkurrenter
Selskap Utbytteavkastning Land
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
0.00%
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
0.00%
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
0.00%
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
0.00%
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
0.83%
IN